Dashboard
Manage Tickers

EBSEmergent BioSolutions Inc.

NYSE emergentbiosolutions.com


$ 2.05 $ 0.18 (9.68 %)    

Friday, 19-Apr-2024 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 414.59 $ -8.76 (-2.07 %)
DIA $ 379.83 $ 1.96 (0.52 %)
SPY $ 494.96 $ -4.36 (-0.87 %)
TLT $ 89.15 $ 0.32 (0.36 %)
GLD $ 221.02 $ 0.69 (0.31 %)
$ 2.04
$ 1.88
$ 0.00 x 0
$ 2.05 x 100
$ 1.88 - $ 2.05
$ 1.42 - $ 10.88
924,755
na
104.45M
$ 1.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-08-2024 12-31-2023 10-K
2 12-11-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-01-2022 06-30-2022 10-Q
8 04-28-2022 03-31-2022 10-Q
9 02-25-2022 12-31-2021 10-K
10 11-05-2021 09-30-2021 10-Q
11 07-30-2021 06-30-2021 10-Q
12 04-30-2021 03-31-2021 10-Q
13 02-19-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
16 05-01-2020 03-31-2020 10-Q
17 02-25-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-02-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 02-22-2019 12-31-2018 10-K
22 11-02-2018 09-30-2018 10-Q
23 08-03-2018 06-30-2018 10-Q
24 05-04-2018 03-31-2018 10-Q
25 02-23-2018 12-31-2017 10-K
26 11-03-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-05-2017 03-31-2017 10-Q
29 02-28-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-05-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-06-2015 09-30-2015 10-Q
35 08-06-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 03-06-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 08-08-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benchmark-reiterates-buy-on-emergent-biosolutions-maintains-5-price-target
Benchmark Reiterates Buy on Emergent BioSo...
04/11/2024 13:05:21

Benchmark analyst Robert Wasserman reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $5 price target.

emergent-biosolutions-receives-nai-status-for-baltimore-bayview-manufacturing-facility
Emergent BioSolutions Receives NAI Status ...
03/25/2024 12:10:10

why-highpeak-energy-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why HighPeak Energy Shares Are Trading Low...
03/07/2024 18:35:19

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-exp...

benchmark-upgrades-emergent-biosolutions-to-buy-announces-5-price-target
Benchmark Upgrades Emergent BioSolutions t...
03/07/2024 15:39:16

Benchmark analyst Robert Wasserman upgrades Emergent BioSolutions (NYSE:EBS) from Hold to Buy and announces $5 price target.

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/07/2024 13:06:06

why-rush-street-interactive-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket
Why Rush Street Interactive Shares Are Tra...
03/07/2024 13:05:46

Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better...

emergent-biosolutions-reports-q4-results-amends-credit-agreement
Emergent BioSolutions Reports Q4 Results, ...
03/06/2024 22:02:06

Emergent BioSolutions reported quarterly losses of 77 cents per share, missing the analyst consensus estimate of losses of 19 c...

emergent-biosolutions-q4-earnings-insights
Emergent BioSolutions: Q4 Earnings Insights
03/06/2024 21:50:18

emergent-biosolutions-sees-fy24-revenue-900m-110b-vs--1184b-est
Emergent BioSolutions Sees FY24 Revenue $9...
03/06/2024 21:22:02

emergent-biosolutions-sees-q1-2024-revenue-200m-250m-vs-185400m-est
Emergent BioSolutions Sees Q1 2024 Revenue...
03/06/2024 21:21:52

emergent-biosolutions-q4-2023-adj-eps-0770-misses-0190-estimate-sales-276600m-miss-293533m-estimate
Emergent BioSolutions Q4 2023 Adj EPS $(0....
03/06/2024 21:19:54

Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.770) per share which missed the analyst consensus estimate of...

earnings-scheduled-for-march-6-2024
Earnings Scheduled For March 6, 2024
03/06/2024 10:00:02

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

earnings-scheduled-for-march-5-2024
Earnings Scheduled For March 5, 2024
03/05/2024 10:00:02

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

emergent-biosolutionss-earnings-a-preview
Emergent BioSolutions's Earnings: A Preview
03/04/2024 19:01:18

whats-going-on-emergent-biosolutions-shares-today
What's Going On Emergent BioSolutions Shar...
02/22/2024 12:35:09

Emergent BioSolutions' shares slide in premarket trading today after ending yesterday's run with a whopping 78% jump. T...

why-international-flavors--fragrances-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why International Flavors & Fragrances Sha...
02/21/2024 18:50:15

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported m...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
02/21/2024 17:31:07

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
02/21/2024 13:06:14

emergent-biosolutions-has-appointed-joseph-papa-as-president-and-ceo-effective-february-21-2024-mr-papa-succeeds-haywood-miller-who-will-step-down-from-his-role-as-interim-ceo
Emergent BioSolutions Has Appointed Joseph...
02/21/2024 12:18:22

fda-announces-shelf-life-extension-for-naloxone-nasal-spray-says-emergent-biosolutions-is-extending-the-shelf-life-of-newly-manufactured-narcan-4-milligram-nasal-spray-products-from-3-years-to-4-years
FDA Announces Shelf-Life Extension For Nal...
01/17/2024 16:01:02

- Reuters 

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)
04/22/2024 Innodata Inc. (INOD)
04/22/2024 Fox Factory Holding Corp. (FOXF)
04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)